As such, gaining a more thorough understanding of the biological pathways behind cancer development is a primary research goal.[37] Here, we analyze the HER2‐positive breast tumor data, a collection of seven datasets that were manually annotated by pathologists as either various healthy tissue regions, noninvasive cancer, or invasive cancer as shown in Figure 3a. The gene discussed is ERBB2; the disease is cancer.